The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease
-
By
-
Yingte Wang
-
Hong Li
-
Jing Zhou
-
Saiyao Zhao
-
Airong Yang
-
Zhiming Li
-
May 8, 2026
-
Clinical Scorecard: The Importance of Multimodal Neuroimaging in Evaluating Monoclonal Antibody Treatments for Alzheimer's Disease
At a Glance
| Category | Detail |
|---|
| Condition | Alzheimer's Disease (AD) |
| Key Mechanisms | Monoclonal antibodies targeting β-amyloid (Aβ) to reduce plaque accumulation and slow disease progression. |
| Target Population | Individuals with early-stage Alzheimer's disease. |
| Care Setting | Clinical settings utilizing neuroimaging for diagnosis and treatment monitoring. |
Key Highlights
- Multimodal neuroimaging enhances diagnostic precision for Alzheimer's disease.
- Structural MRI identifies cerebral atrophy and amyloid-related imaging abnormalities (ARIA).
- PET imaging quantifies Aβ plaque reduction as a biomarker for treatment response.
- AI technologies improve imaging data analysis and clinical decision-making.
- Standardized imaging protocols are essential for maximizing therapeutic benefits.
Guideline-Based Recommendations
Diagnosis
- Utilize multimodal neuroimaging (sMRI, PET, fMRI) for accurate diagnosis of Alzheimer's disease.
Management
- Implement regular MRI assessments to monitor for ARIA in patients receiving anti-Aβ monoclonal antibody treatments.
Monitoring & Follow-up
- Conduct longitudinal imaging studies to evaluate treatment efficacy and safety.
Risks
- Monitor for amyloid-related imaging abnormalities (ARIA) as a significant side effect of treatment.
Patient & Prescribing Data
Patients with early-stage Alzheimer's disease.
Monoclonal antibodies like lecanemab and donanemab show potential in slowing clinical deterioration but may have limited cognitive benefits.
Clinical Best Practices
- Adopt interdisciplinary collaboration for comprehensive patient evaluation.
- Utilize AI-driven modeling to enhance imaging data interpretation.
- Standardize imaging protocols to improve diagnostic and treatment outcomes.
References
